COMMUNIQUÉS West-GlobeNewswire

-
VBL Final Phase 1/2 Study Results Presented at ASCO Demonstrate VB-111 Dose Dependent Increase in Overall Survival and 58% CA-125 Response Rate in Platinum-Resistant Ovarian Cancer
03/06/2019 -
Radiographic Analysis of VB-111 Phase 2 and 3 Clinical Trials in Recurrent Glioblastoma Shows Survival Benefit Associated with Objective Responses and Distinct Signature of VB-111 Activity
03/06/2019 -
Scapa Healthcare Opens New Medical Device Manufacturing Facility in Knoxville, TN
03/06/2019 -
Imagin Medical to Report Second Fiscal Quarter 2019 Financial Results on June 11, 2019 – Conference Call to Follow
03/06/2019 -
Kaleido Biosciences to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
03/06/2019 -
TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage
03/06/2019 -
Cellworks myCare™ Clinical Trial Transforms NGS Data into Personalized Cancer Therapy Actions
03/06/2019 -
Forty Seven, Inc. Announces Updated Initial Data from Phase 1b Clinical Trial of 5F9 in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia
03/06/2019 -
Cue Biopharma to Present Corporate Overview & Clinical Strategy for CUE-101 at Jefferies 2019 Healthcare Conference
03/06/2019 -
Afrezza® (insulin human) Inhalation Powder Approved in Brazil
03/06/2019 -
Vaccinex Presents Updated Interim Results from a Phase 1b/2 Study of Pepinemab in Combination with Avelumab in Non-Small Cell Lung Cancer at the 2019 ASCO Annual Meeting
03/06/2019 -
Agios Presents Updated Data from Phase 1 Studies of TIBSOVO® (ivosidenib) in Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy
03/06/2019 -
Progenics Pharmaceuticals Mails Letter to Shareholders
03/06/2019 -
Neon Therapeutics to Present at Jefferies 2019 Healthcare Conference
03/06/2019 -
Immutep Presentation at ASCO 2019
03/06/2019 -
Humanigen to Present at the Jefferies 2019 Healthcare Conference
03/06/2019 -
AIT Therapeutics to Participate at Jefferies 2019 Global Healthcare Conference
03/06/2019 -
Outlook Therapeutics Signs Manufacturing Supply Agreement with FUJIFILM Diosynth Biotechnologies as Part of Commercialization Strategy for ONS-5010
03/06/2019 -
Todos Medical Announces Positive Clinical Trial Data for Breast Cancer Blood Test TM-B1 in Dense Breasts
03/06/2019
Pages